OCT2 activators belong to a diverse class of chemical compounds that enhance the functional activity of Organic Cation Transporter 2 (OCT2), a membrane protein primarily involved in the cellular uptake of organic cations. The structure-activity relationship of OCT2 activators is not strictly defined, as they can come from a variety of chemical classes, including small organic molecules, dietary nutrients, and environmental agents. These activators can modulate OCT2 at different levels, including transcriptional, translational, or post-translational modifications, which in turn can affect the transporter's density at the cell membrane, its affinity for substrates, or the transporter's intrinsic activity. Some activators interact directly with the transporter, altering its conformation to enhance substrate binding or transport kinetics. Others may exert their effect indirectly, such as by influencing cellular signaling pathways that lead to an increase in OCT2 expression or by stabilizing the transporter protein to prolong its functional lifespan in the cellular membrane.
The functional upregulation of OCT2 by these activators is an area of interest due to its role in the cellular uptake of a wide spectrum of endogenous and exogenous organic cations, including metabolic byproducts and environmental toxins. This process is particularly pertinent in the renal system, where OCT2 plays a significant role in the handling of organic cations in the kidneys. The inducers may act through various mechanisms, such as the activation of transcription factors that bind to the promoter region of the OCT2 gene, thereby enhancing its transcription. Alternatively, post-transcriptional mechanisms may include the stabilization of OCT2 mRNA, leading to a prolonged half-life and increased translation. Additionally, post-translational modifications, such as phosphorylation, ubiquitination, or glycosylation, can affect OCT2's activity and trafficking to the cellular membrane, where it carries out its function.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a metabolite of vitamin A, has been shown to affect the expression of various transporters and may modulate OCT2 expression through nuclear receptor-mediated pathways. | ||||||
Cholecalciferol | 67-97-0 | sc-205630 sc-205630A sc-205630B | 1 g 5 g 10 g | $71.00 $163.00 $296.00 | 2 | |
Cholecalciferol can influence gene expression via its receptor, which might also affect OCT2 levels as part of the regulatory mechanisms of electrolyte homeostasis. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin, a chemotherapy agent, could increase OCT2 expression as a compensatory mechanism for enhanced renal secretion of organic cations in response to nephrotoxicity. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporine A may upregulate OCT2 as a part of a feedback response due to its own role as a substrate for organic cation transporters in renal cells. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol might influence OCT2 expression through estrogen receptors, which can act on the regulatory elements of genes coding for various transporters. | ||||||
Indinavir | 150378-17-9 | sc-353630 | 100 mg | $982.00 | 1 | |
As an antiretroviral protease inhibitor, indinavir may upregulate OCT2 as a means of ensuring its own efficient renal clearance. | ||||||